Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1170 studies found for:    Uterine Diseases: Clinical Trials
Show Display Options
Rank Status Study
21 Unknown  A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer
Condition: Prosthesis Survival
Interventions: Radiation: radiotherapy;   Drug: Cisplatin;   Drug: Cisplatin and Doxorubicin and Cyclophosphamide;   Drug: Paclitaxel and Carboplatin
22 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)
23 Active, not recruiting Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Fallopian Cancer;   Peritoneal Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
24 Completed An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060)
Condition: Contraception
Interventions: Drug: Etonogestrel-releasing IUS;   Device: Multiload-cu 375®
25 Unknown  Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
26 Recruiting Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Uterine Cancer;   Mesotheliomas;   Gastrointestinal Cancers;   Cervical Cancer
Interventions: Device: HIPEC: MMC 30mg @ T0, 10mg @ T45min;   Device: HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0;   Device: HIPEC: CDDP 75 mg/m2 @T0;   Device: HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0
27 Withdrawn Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)
Conditions: Cervical Cancer;   Condylomata Acuminata
Intervention: Biological: V502
28 Recruiting A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
Condition: Cervical Dysplasia
Intervention: Drug: Nelfinavir
29 Active, not recruiting Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer;   Uterine Cervical Cancer
Interventions: Drug: Filgrastim;   Drug: Paclitaxel;   Drug: Carboplatin
30 Suspended Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Conditions: Endometrial Cancer;   Gastrointestinal Complications;   Radiation Toxicity;   Urinary Complications
Intervention: Radiation: 45 Gy/25 fractions
31 Completed Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity
Conditions: Infection; Cesarean Section;   Surgical Wound Infection;   Endometritis
Interventions: Other: 80% inhaled oxygen via non-rebreather mask;   Other: 30% inhaled oxygen via nasal cannula
32 Completed Chlorhexidine as Coadjuvant in Dentin Adhesion of Noncarious Cervical Lesions
Condition: Non-carious Cervical Lesions
Interventions: Procedure: Treatment with chlorhexidine;   Procedure: Water pre-treatment
33 Completed Efficacy Study of Vaginal Mesh for Prolapse
Conditions: Pelvic Organ Prolapse;   Uterine Prolapse;   Vaginal Prolapse;   Cystocele;   Rectocele
Intervention: Device: synthetic monofilament polypropylene mesh
34 Completed A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
Condition: Uterine Cancer
Interventions: Drug: Ifosfamide;   Procedure: Radiation Therapy
35 Active, not recruiting Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: Radiation Therapy;   Drug: cisplatin;   Drug: carboplatin;   Drug: Paclitaxel
36 Not yet recruiting Clinical Trial Safety and Feasibility of TA-CIN Vaccine in Combination With GPI-0100 Adjuvant in Patients With a History of HPV16 Associated Cervical Cancer
Condition: HPV16 Associated Cervical Cancer
Intervention: Biological: TA-CIN/GPI-0100
37 Completed Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage IVB Cervical Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Drug: Topotecan Hydrochloride;   Drug: Vinorelbine Tartrate
38 Recruiting Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small -Cell Lung;   Ovarian Neoplasms;   Small Cell Lung Carcinoma;   Uterine Cervical Neoplasms;   Carcinoma, Neuroendocrine
Interventions: Drug: Topotecan;   Drug: VX-970
39 Completed LESS-TLH Versus LESS-LAVH
Condition: Benign Uterine Disease
Interventions: Procedure: LESS-TLH;   Procedure: LESS-LAVH
40 Recruiting A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Conditions: Sexual Dysfunctions, Psychological;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: GyneGals Support Group

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years